Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB26FX1KT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,137
Award facts
- Contract value 100% obligated
- $49,137.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $49,137.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The award was issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizing firm fixed-price terms with no set-aside designation. DMS Pharmaceutical Group Inc. competed on an unrestricted basis, demonstrating the company's competitive capability in federal pharmaceutical procurement.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a $500 million ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors. DMS Pharmaceutical Group's extensive product portfolio encompasses branded and generic prescription medications, biologics, specialty pharmaceuticals, and medical consumables, establishing the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FX1KT?
SPE2DB26FX1KT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX1KT worth?
The government has obligated $49,137 on SPE2DB26FX1KT.
Is contract SPE2DB26FX1KT an order under another contract?
Yes. SPE2DB26FX1KT is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1KT competed?
The extent of competition for SPE2DB26FX1KT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award